[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100545918":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":17,"responsibleParty":34,"collaborators":7,"id":38,"slug":39,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":7,"eligibilityCriteria":44,"healthyVolunteers":40,"sex":45,"minAge":46,"maxAge":47,"enrollmentInfo":48,"targetDuration":7,"studyType":51,"phases":7,"briefSummary":52,"conditions":53,"keywords":7,"overallStatus":20,"whyStopped":7,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":65},{"fullName":5,"class":6},"Second Affiliated Hospital, School of Medicine, Zhejiang University","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Chunhong Shen","PRINCIPAL_INVESTIGATOR",[13],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","+86 0571 87783872","shen_neurology@zju.edu.cn",[18],{"facility":19,"status":20,"city":21,"state":22,"zip":23,"country":24,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"2nd Affiliated Hospital, School of Medicine, Zhejiang University, China","RECRUITING","Hangzhou","Zhejiang","310000","China","CN",{"type":27,"coordinates":28},"Point",[29,30],120.16142,30.29365,{"lat":30,"lon":29},[33],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},{"type":35,"investigatorFullName":36,"investigatorTitle":37,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"SPONSOR_INVESTIGATOR","Shen Chun-Hong","Associate Senior Doctor","100545918","idiopathic-generalized-epilepsy-syndromes-100545918",false,"NCT06388174","Idiopathic Generalized Epilepsy Syndromes","Idiopathic Generalized Epilepsy Syndromes: Clinical Features and Long-term Outcomes","Inclusion Criteria:\n\n* Patients are consecutively and prospectively enrolled from epilepsy center, with newly diagnosed epilepsy or established epilepsy.\n* Patients have a diagnosis of idiopathic generalized epilepsy (IGE), according to the 2022 diagnostic criteria.\n* Comprehensive clinical information is collected, and 24 hour video-electroencephalography is performed.\n* Sign the informed consent forms.\n\nExclusion Criteria:\n\n* Other epilepsy syndromes are considered during follow-up, such as genetic generalized epilepsy.\n* Lost to follow-up","ALL","4 Years","40 Years",{"count":49,"type":50},200,"ESTIMATED","OBSERVATIONAL","The idiopathic generalized epilepsies (IGEs) have historically included the syndromes childhood absence epilepsy (CAE), juvenile absence epilepsy (JAE), juvenile myoclonic epilepsy (JME), and epilepsy with generalized tonic-clonic seizures alone (GTCA). Recognition of the IGEs is important for clinical care, as it informs diagnosis, prevents unnecessary investigation, allows optimal selection of anti-seizure medications (ASMs), and provides prognostic guidance.\n\nAccording to the new ILAE definition in 2022, the study aims to describe the clinical features, electroencephalographic, imaging findings and long-term prognosis.",[54,55],"Epilepsy","Epilepsy, Idiopathic Generalized","2025-08-20",{"date":58,"type":59},"2025-08-27","ACTUAL",{"date":61,"type":59},"2023-01-01",{"date":63,"type":50},"2033-12-31",{"name":36,"class":6},1]